Paid Clinical Trials Orange County
Discover 2,473 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Observational StudyAmyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
Sponsor:
Novoic Limited
Location:
Code:
NCT04937959
Conditions
Alzheimer Disease
Alzheimer's Disease (Incl Subtypes)
Preclinical Alzheimer's Disease
Prodromal Alzheimer's Disease
Mild Cognitive Impairment
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Accepted
FarudodstatInvestigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Sponsor:
ASLAN Pharmaceuticals
Location:
Code:
NCT05865041
Conditions
Alopecia Areata
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Farudodstat
Placebo
MiricorilantA Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
Sponsor:
Corcept Therapeutics
Location:
Code:
NCT06108219
Conditions
Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Miricorilant (Cohort A)
Placebo (Cohort A)
Miricorilant (Cohort B)
Placebo (Cohort B)
Salivary miRNAValidation of a Salivary miRNA Diagnostic Test for ASD
Sponsor:
Quadrant Biosciences Inc.
Location:
Code:
NCT05418023
Conditions
Autism Spectrum Disorder
Developmental Delay
Eligibility Criteria
Sex: All
Age: 18 - 7
Healthy Volunteers: Not accepted
Interventions
Salivary Collection
Adaptive Assessment
Medical and Demographic questionnaire
Autism Assessment
Intellectual Development Assessment
Observational StudyEmpowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)
Sponsor:
UCLA
Location:
Code:
NCT06225414
Conditions
Lung Cancer
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Accepted
Interventions
Usual Care
Brief Patient Education
Patient education
Referral to financial navigation resources
Patient Reminders
CGB-500 with TofacitinibPhase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Sponsor:
CAGE Bio Inc.
Location:
Code:
NCT06810050
Conditions
Atopic Dermatitis (AD)
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
CGB-500 with 0.5% tofacitinib
CGB-500 Ointment with 1% tofacitinib
Vehicle (placebo)
MindfulnessConscious Pregnancy: Supporting Maternal Cardiometabolic Health With Mindfulness
Sponsor:
UCLA
Location:
Code:
NCT06898658
Conditions
Maternal Cardiometabolic Health
Molecular Impact of Psychological Stress and Socioeconomic Adversity
Maternal Inflammatory Markers
Maternal Diabetes
Maternal Behavior
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Accepted
Interventions
Mindfulness Intervention
HBI-2438A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Sponsor:
HUYABIO International, LLC.
Location:
Code:
NCT05485974
Conditions
Lung Cancer
Non Small Cell Lung Cancer
Colorectal Cancer
Cancer of Pancreas
Colon Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HBI-2438
ElamipretideReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Sponsor:
Stealth BioTherapeutics Inc.
Location:
Code:
NCT06373731
Conditions
Age Related Macular Degeneration (ARMD)
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Not accepted
Interventions
Elamipretide
Placebo